Anti-ST7L monoclonal antibody

Pre-made anti-ST7L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ST7L/ST7L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1834-Ab-1/ GM-Tg-hg-IP1834-Ab-2Anti-Human ST7L monoclonal antibodyHuman
GM-Tg-rg-IP1834-Ab-1/ GM-Tg-rg-IP1834-Ab-2Anti-Rat ST7L monoclonal antibodyRat
GM-Tg-mg-IP1834-Ab-1/ GM-Tg-mg-IP1834-Ab-2Anti-Mouse ST7L monoclonal antibodyMouse
GM-Tg-cynog-IP1834-Ab-1/ GM-Tg-cynog-IP1834-Ab-2Anti-Cynomolgus/ Rhesus macaque ST7L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1834-Ab-1/ GM-Tg-felg-IP1834-Ab-2Anti-Feline ST7L monoclonal antibodyFeline
GM-Tg-cang-IP1834-Ab-1/ GM-Tg-cang-IP1834-Ab-2Anti-Canine ST7L monoclonal antibodyCanine
GM-Tg-bovg-IP1834-Ab-1/ GM-Tg-bovg-IP1834-Ab-2Anti-Bovine ST7L monoclonal antibodyBovine
GM-Tg-equg-IP1834-Ab-1/ GM-Tg-equg-IP1834-Ab-2Anti-Equine ST7L monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1834-Ab-1/ GM-Tg-hg-IP1834-Ab-2; GM-Tg-rg-IP1834-Ab-1/ GM-Tg-rg-IP1834-Ab-2;
GM-Tg-mg-IP1834-Ab-1/ GM-Tg-mg-IP1834-Ab-2; GM-Tg-cynog-IP1834-Ab-1/ GM-Tg-cynog-IP1834-Ab-2;
GM-Tg-felg-IP1834-Ab-1/ GM-Tg-felg-IP1834-Ab-2; GM-Tg-cang-IP1834-Ab-1/ GM-Tg-cang-IP1834-Ab-2;
GM-Tg-bovg-IP1834-Ab-1/ GM-Tg-bovg-IP1834-Ab-2; GM-Tg-equg-IP1834-Ab-1/ GM-Tg-equg-IP1834-Ab-2
Products NameAnti-ST7L monoclonal antibody
Formatmab
Target NameST7L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ST7L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1834-Ag-1Recombinant multi-species ST7L/ FAM4B/ ST7R protein


    Target information

    Target IDGM-IP1834
    Target NameST7L
    Gene ID54879,229681,295344,705541,612836,101097661,534657,100059051
    Gene Symbol and SynonymsFAM4B,ST7L,ST7R,STLR
    Uniprot AccessionQ8TDW4,Q68FW3,A3KN28
    Uniprot Entry NameST7L_HUMAN,ST7L_RAT,ST7L_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000007341
    Target ClassificationN/A

    The target: ST7L, gene name: ST7L, also named as FAM4B, ST7R, STLR. This gene was identified by its similarity to the ST7 tumor suppressor gene found in the chromosome 7q31 region. This gene is clustered in a tail-to-tail manner with the WNT2B gene in a chromosomal region known to be deleted and rearranged in a variety of cancers. Several transcript variants encoding many different isoforms have been described, but some have not been fully characterized. [provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.